Thyroid hormones and the central nervous system of mammals (Review)

Molecular Medicine Reports

Volumn 1, Issue 3, 2008, Pages 279-295

  Di Liegro, Italia ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Brain development; Brain functions; Central nervous system; Non genomic actions; Nuclear receptors; Thyroid hormones

Indexed keywords

CELL NUCLEUS RECEPTOR; INTEGRIN; LEVOTHYROXINE; LIOTHYRONINE; THYROID HORMONE; THYROID HORMONE RECEPTOR;

BRAIN DEVELOPMENT; BRAIN MATURATION; BRAIN TISSUE; CELL MEMBRANE; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE ACTIVATION; GENE REPRESSION; GENOME ANALYSIS; HORMONE ACTION; HORMONE BINDING; HORMONE DEFICIENCY; HORMONE DETERMINATION; HORMONE SYNTHESIS; HORMONE TRANSPORT; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAMMAL; MITOCHONDRION; MOTOR DYSFUNCTION; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NONHUMAN; ONTOGENY; REVIEW; THYROID HORMONE RESISTANCE;

MAMMALIA;

EID: 69249155091     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.1.3.279     Document Type: Review

References (253)

1. Yen PM: Physiological and molecular basis of thyroid hormone action. Physiol Rev 81: 1097-1142, 2001. (Pubitemid 32606667)
2. Kendall EC: The isolation in crystalline form of the compound containing iodine which occurs in the thyroid: its chemical nature and physiological activity. Trans Assoc Am Physicians 30: 420-449, 1915.
3. Gross J and Pitt-Rivers R: Triiodothyronine in relation to thyroid physiology. Recent Prog Horm Res 10: 109-128, 1954.
4. Tata JR, Ernster L, Lindberg O, Arrhenius ESP and Hedman R: The action of thyroid hormones at the cell level. Biochem J 86: 408-428, 1963.
5. Tata JR and Widnell CC: Ribonucleic acid synthesis during the early action of thyroid hormones. Biochem J 98: 604-629, 1966.
6. Oppenheimer JK, Koerner D, Scwartz HL and Surks MI: Specific nuclear triiodothyronine binding sites in rat liver and kidney. J Clin Endocrinol Metab 73: 330-333, 1972.
7. Samuels HH and Tsaj JS: Thyroid hormone action in cell culture: demonstration of nuclear receptors in intact cells and isolated nuclei. Proc Natl Acad Sci USA 70: 3488-3492, 1973.
8. Oppenheimer JK, Scwartz HL and Surks MI: Tissue differences in the concentration of triiodothyronine nuclear binding sites in the rat: liver, kidney, pituitary, heart, brain, spleen, and testis. Endocrinology 95: 897-903, 1974.
9. Pascual AS, Casanova J and Samuels HH: Photoaffinity labelling of thyroid hormone receptors in intact cells. J Biol Chem 257: 9640-9647, 1982. (Pubitemid 13205128)
10. Dozin B, Cahnmann HJ and Nikodem VM: Identification of thyroid hormone receptors in rat liver nuclei by photoaffinity labelling with L-thyroxine and triiodothyronine. Biochemistry 24: 5197-5202, 1985. (Pubitemid 15242626)
11. Magnuson MA, Dozin B and Nikodem VM: Regulation of specific rat liver messenger ribonucleic acids by triiodo-thyronine. J Biol Chem 260: 5906-5912, 1985. (Pubitemid 15072487)
12. Crew CD and Spindler SR: Thyroid hormone regulation of the transfected rat growth hormone promoter activity. J Biol Chem 261: 5018-5022, 1986. (Pubitemid 17204296)
13. Izumo S, Nadal-Ginard B and Mahdavi V: All the members of the MHC multigene family respond to thyroid hormone in a highly tissue-specific manner. Science 231: 597-600, 1986. (Pubitemid 16088941)
14. Larsen PR, Harney JW and Moore DD: Sequences required for cell-specific thyroid hormone regulation of rat growth hormone promoter activity. J Biol Chem 261: 14733-14736, 1986.
15. Lavin TN, Baxter JD and Horita S: The thyroid hormone receptor binds to multiple domains of the rat growth hormone 5′-flanking sequence. J Biol Chem 263: 9418-9426, 1988.
16. Samuels HH, Forman BM, Horowitz ZD and Ye S: Regulation of gene expression by thyroid hormones. J Clin Invest 81: 957-967, 1988. (Pubitemid 18128055)
17. Hollenberg SM, Weinberger C and Ong ES: Primary structure and expression of a functional glucocorticoid receptor cDNA. Nature 318: 635-641, 1885.
18. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P and Chambon P: Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320: 134-139, 1986. (Pubitemid 16105150)
19. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ and Evans RM: The c-erbA gene encodes a thyroid hormone receptor. Nature 324: 641-646, 1986. (Pubitemid 17206351)
20. Sap J, Munoz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H and Vennstrom B: The c-erbA protein is a high affinity receptor for thyroid hormone. Nature 324: 635-640, 1986. (Pubitemid 17206350)
21. Izumo S and Mahadavi V: Thyroid hormone receptor α isoforms generated by alternative splicing differentially activate myosin HC gene transcription. Nature 334: 539-542, 1988. (Pubitemid 18190386)
22. Lazar MA, Hodin RA, Darling DS and Chin WW: Identification of a rat c-erbAα-related protein which binds deoxyribonucleic acid and does not bind thyroid hormone. Mol Endocrinol 2: 893-901, 1988.
23. Lazar MA, Hodin RA, Darling DS and Chin WW: A novel member of the thyroid/steroid hormone receptor family is encoded by the opposite strand of the rat c-erbAα transcriptional unit. Mol Cell Biol 9: 1128-1136, 1989.
24. Mitsuhashi TG, Tennyson GE and Nikodem VM: Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone. Proc Natl Acad Sci USA 85: 684-693, 1988.
25. Cook CB and Koenig RJ: Expression of erbA alpha and beta mRNAs in regions of adult rat brain. Mol Cell Endocrinol 70: 13-20, 1990.
26. Castiglia D, Cestelli A, Di Liegro C, Bonfanti L and Di Liegro I: Accumulation of different c-erbA transcripts during rat brain development and in cortical neurons cultured in a synthetic medium. Cell Mol Neurobiol 12: 259-272, 1992.
27. Strait KA, Zou L and Oppenheimer JH: Beta 1 isoform-specific regulation of a triiodothyronine-induced gene during cerebellar development. Mol Endocrinol 6: 1874-1880, 1992.
28. Weiss RM and Noback CR: The effect of thyroxine and thiouracil on the time of appearance of ossification centers of rat fetuses. Endocrinology 45: 389-395, 1949.
29. Morreale de Escobar G, Pastor R, Obregon MJ and Escobar del Rey F: Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. Endocrinology 117: 1890-1900, 1985.
30. Bianco AC, Salvatore D, Gereben B, Berry MJ and Larsen PR: Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23: 38-89, 2002. (Pubitemid 34185306)
31. Morreale de Escobar G, Obregon MJ and Escobar del Rey F: Maternal thyroid hormones early in pregnancy and fetal brain development. Best Pract Res Clin Endocrinol Metab 18: 225-248, 2004. (Pubitemid 38807301)
32. Huang SA, Dorfman DM, Genest DR, Salvatore D and Larsen PR: Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab 88: 1384-1388, 2003. (Pubitemid 36337804)
33. Gray B and Galton VA: The transplacental passage of thyroxine and foetal thyroid function in the rat. Acta Endocrinol 75: 725-733, 1974.
34. Sweney LR and Shapiro BL: Thyroxine and palatal development in the rat. Dev Biol 42: 19-27, 1975.
35. Porterfield SP and Hendrich CE: The effects of growth hormone treatment of thyroid-deficient pregnant rats on maternal and fetal carbohydrate metabolism. Endocrinology 99: 786-792, 1976.
36. Man EB and Serunian SA: Thyroid function in human pregnancy. IX. Development or retardation of 7-year-old progeny of hypothyroxinemic women. Am J Obstet Gynecol 125: 949, 1976.
37. Obregon MJ, Mallol J, Pastor R, Morreale del Escobar G and Escobar del Rey F: Thyroxine and 3,5,5′-triiodothyronine in rat embryos before onset of fetal thyroid function. Endocrinology 114: 305-307, 1984. (Pubitemid 14221908)
38. Woods RJ, Sinha AK and Ekins R: Uptake and metabolism of thyroid hormones by the rat foetus in early pregnancy. Clin Sci 67: 359-363, 1984.
39. Escobar del Rey F, Pastor R, Mallol J and Morreale de Escobar G: Effects of maternal iodide deficiency on the L-thyroxine and 3,5,3′-triiodo-L- thyronine contents of rat embryonic tissues before and after onset of fetal thyroid function. Endocrinology 118: 1259-1265, 1986. (Pubitemid 16078494)
40. Ruiz de Oña C, Obregon MJ, Escobar del Rey F and Morreale de Escobar G: Developmental changes in rat brain 5′-deiodinase and thyroid hormones during the fetal period: the effects of fetal hypothyroidism and maternal thyroid hormones. Pediatr Res 24: 588-594, 1988. (Pubitemid 18266168)
41. James SR, Franklin JA and Kilby MD: Placental transport of thyroid hormone. Best Pract Res Clin Endocrinol Metab 21: 253-264, 2007.
42. Calvo RM, Jauniaux E, Gulbis B, Asunción M, Gervy C, Contempré B and Morreale de Escobar G: Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development. J Clin Endocrinol Metab 87: 1768-1777, 2002. (Pubitemid 34615267)
43. Koopdonk-Kool JM, De Vijlder JJ, Veenboer GJ, Ris-Stalpers C, Kok JH, Vulsma T, Boer K and Visser TJ: Type II and type III deiodinase activity in human placenta as a function of gestation age. J Clin Endocrinol Metab 81: 2154-2158, 1996. (Pubitemid 26175941)
44. Santini F, Chiovato L, Ghirri P, Lapi P, Mammoli C, Montanelli L, Scartabelli G, Ceccarini G, Coccoli L, Chopra IJ, Boldrini A and Pichera A: Serum iodothyronines in the human fetus and the newborn: evidence for an important role of placenta in fetal thyroid hormone homeostasis. J Clin Endocrinol Metab 84: 493-498, 1999. (Pubitemid 29075674)
45. Chan S, Kachilele S, Hobbs E, Bulmer JN, Boelaert K, McCabe CJ, Driver PM, Bradwell AR, Kester M, Visser TJ, Franklyn JA and Kilby MD: Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab 88: 4488-4495, 2003. (Pubitemid 37153761)
46. Di Liegro I, Savettieri G and Cestelli A: Cellular mechanism of action of thyroid hormones. Differentiation 35: 165-175, 1987. (Pubitemid 18031039)
47. Bernal J and De Groot LJ: Mode of action of thyroid hormone. In: The Thyroid Gland. De Visscher M (ed). Raven Press, New York, pp123-143, 1980.
48. Kolodny JM, Larsen PR and Silva JE: In vitro 3,5,3′- triiodothyronine binding to rat cerebrocortical neuronal and glial nuclei suggests the presence of binding sites unavailable in vivo. Endocrinology 116: 2019-2028, 1985.
49. Margarity M, Matsokis N and Valcana T: Characterization of nuclear triiodothyronine (T3) and tetraiodothyronine (T4) binding in developing brain tissue. Mol Cell Endocrinol 31: 333-351, 1983.
50. Oppenheimer JH: Thyroid hormone action at the cellular level. Science 203: 971-979, 1979. (Pubitemid 9151632)
51. Aranda A and Pascual A: Nuclear hormone receptors and gene expression. Physiol Rev 81: 1269-1304, 2001. (Pubitemid 32606670)
52. Zhang J and Lazar MA: The mechanism of action of thyroid hormones. Annu Rev Physiol 62: 439-466, 2000.
53. Wu Y and Koenig RJ: Gene regulation by thyroid hormones. Trends Endocrinol Metab 11: 207-211, 2000.
54. McKenna NJ and O'Malley BW: Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108: 465-474, 2002. (Pubitemid 34260872)
55. Nevado J, Tenbaum SP and Aranda A: hSrb7, an essential human mediator component, acts as a coactivator for thyroid hormone receptor. Mol Cell Endocrinol 222: 41-51, 2004. (Pubitemid 38900814)
56. Katz RW, Subauste JS and Koenig RJ: The interplay of half-site sequence and spacing on the activity of direct repeat TH response elements. J Biol Chem 270: 5238-5242, 1995.
57. Cheng S-Y: Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord 1: 9-18, 2000.
58. Cheng S-Y: Isoform-dependent action of thyroid hormone nuclear receptors: lessons from knockin mutant mice. Steroids 70: 450-454, 2005.
59. Wahlstrom GM, Sjoberg M, Andersson M, Nordström K and Vennström B: Binding characteristic of the TH receptor homoand heterodimers to consensus AGGTCA repeat motifs. Mol Endocrinol 6: 1013-1022, 1992.
60. Zechel C, Shen XQ, Chen JY, Chen ZP, Chambon P and Gronemeyer H: The dimerization interfaces formed between the DNA binding domains of RXR, RAR and TR determine the binding specificity and polarity of the full-length receptors to direct repeats. EMBO J 13: 1425-1433, 1994.
61. Desvergne B: How do thyroid hormone receptors bind to structurally diverse response elements? Mol Cell Endocrinol 100: 125-131, 1994.
62. Wu Y, Xu B and Koenig RJ: Thyroid hormone response element sequence and the recruitment of retinoid X receptors for thyroid hormone responsiveness. J Biol Chem 276: 3929-3936, 2001. (Pubitemid 37371472)
63. Velasco LF, Togashi M, Walfish PG, Pessanha RP, Moura FN, Barra GB, Nguyen P, Rebong R, Yuan C, Simeoni LA, Ribeiro RC, Baxter JD, Webb P and Neves FA: Thyroid hormone element organization dictates the composition of active receptor. J Biol Chem 282: 12458-12466, 2007. (Pubitemid 47100577)
64. Nascimento AS, Gomes Dias SM, Nunes FM, Aparício R, Ambrosio ALB, Bleicher L, Figueira ACM, Santos MAM, De Oliveira Neto M, Fischer H, Togashi M, Craievich AF, Garratt RC, Baxter JD, Webb P and Polikarpov I: Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function. J Mol Biol 360: 586-598, 2006. (Pubitemid 43975107)
65. Mengeling BJ, Lee S and Privalsky ML: Coactivator recruitment is enhanced by thyroid hormone receptor trimers. Mol Cell Endocrinol 280: 47-62, 2008. (Pubitemid 350184201)
66. Hyyti OM and Portman MA: Molecular mechanisms of cross-talk between thyroid hormone and peroxisome proliferator activated receptors: focus on the heart. Cardiovasc Drugs Ther 20: 463-469, 2006.
67. Weisbrod S: Active chromatin. Nature 297: 289-295, 1982.
68. Weintraub H: Assembly and propagation of repressed and suppressed chromosomal states. Cell 42: 705-711, 1985.
69. Nyborg JK and Spindler SR: Alterations in local chromatin structure accompany thyroid hormone induction of growth hormone gene transcription. J Biol Chem 261: 5685-5688, 1986.
70. Usala SJ, Young WS III, Morioka H and Nikodem VM: The effect of thyroid hormone on the chromatin structure and expression of the malic enzyme in hepatocytes. Mol Endocrinol 2: 619-626, 1988. (Pubitemid 18174446)
71. Williams GR and Brent GA: Thyroid hormone response elements. In: Molecular Endocrinology: Basic Concepts and Clinical Correlations. Weintraub B (ed). Raven Press, New York, pp217-239, 1995.
72. Feng X, Yuan J, Meltzer PB and Yen PM: TH regulation of hepatic genes in vivo detected by cDNA microarray. Mol Endocrinol 14: 947-955, 2000.
73. Flores-Morales A, Gullberg H, Fernandez L, Ståhlberg N, Lee NH, Vennström B and Norstedt G: Pattern of liver gene expression governed by TRbeta. Mol Endocrinol 16: 1257-1268, 2002. (Pubitemid 34621074)
74. Smith CL and O'Malley BW: Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endrocr Rev 25: 45-71, 2004.
75. Spiegelman BM and Heinrich R: Biological control through regulated transcriptional coactivators. Cell 119: 157-167, 2004.
76. Rosenfeld MG, Lunyak VV and Glass CK: Sensors and signals: a coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev 20: 1405-1428, 2006.
77. Feige JN and Auwerx J: Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol 17: 292-301, 2007. (Pubitemid 46829846)
78. Méndez-Pertuz M, Sánchez-Pacheco A and Aranda A: The thyroid hormone receptor antagonizes CREB-mediated transcription. EMBO J 22: 3102-3112, 2003. (Pubitemid 36758630)
79. García-Silva S and Aranda A: The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation, and transformation. Mol Cell Biol 24: 7514-7523, 2004. (Pubitemid 39121479)
80. Perez-Juste G and Aranda A: The cyclin-dependent kinase inhibitor p27 (kip1) is involved in thyroid hormone-mediated neuronal differentiation. J Biol Chem 274: 5026-5031, 1999. (Pubitemid 129501521)
81. Ogryzko VV, Schiltz RL, Russanova V, Howard BH and Nakatani Y: The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87: 953-959, 1996. (Pubitemid 26404293)
82. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ and O'Malley BW: Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389: 194-198, 1997. (Pubitemid 27400603)
83. Oetting A and Yen PM: New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 21: 193-208, 2007. (Pubitemid 46888201)
84. Li D, Desai-Yajnik V, Lo E, Schapira M, Abagyan R and Samuels HH: NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors. Mol Cell Biol 19: 7191-7202, 1999. (Pubitemid 29441899)
85. Horlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK and Rosenfeld MG: Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404, 1995.
86. Chen JD and Evans RM: A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457, 1995.
87. Jepsen K, Hermanson O, Onami TM, Gleiberman AS, Lunyak V, McEvilly RJ, Kurokawa R, Kumar V, Liu F, Seto E, Hedrick SM, Mandel G, Glass CK, Rose DW and Rosenfeld MG: Combinatorial roles of the nuclear receptor corepressors in transcription and development. Cell 102: 753-763, 2000.
88. Hermanson O, Jepsen K and Rosenfeld MG: N-CoR controls differentiation of neural stem cells into astrocytes. Nature 419: 934-939, 2002. (Pubitemid 35339628)
89. Malartre M, Short S and Sharpe C: Xenopus embryos lacking specific isoforms of the corepressor SMRT develop abnormal heads. Dev Biol 292: 333-343, 2006.
90. Gurevich I, Flores AM and Aneskievich BJ: Corepressors of agonist-bound nuclear receptors. Toxicol Appl Pharmacol 223: 288-298, 2007.
91. Koenig RJ, Lazar MA, Hodin RA, Brent GA, Larsen PR, Chin WW and Moore DD: Inhibition of TH action by a nonhormone binding c-erbA protein generated by alternative mRNA splicing. Nature 337: 659-661, 1989.
92. Katz D, Berrodin TJ and Lazar MA: The unique C-termini of the TH-receptor variant, c-erbAa2, and TH receptor a1 mediate different DNA-binding and heterodimerization properties. Mol Endocrinol 6: 805-814, 1992.
93. Nagaya T and Jameson JL: Distinct dimerization domains provide antagonist pathways for TH receptor action. J Biol Chem 268: 24278-24282, 1993. (Pubitemid 23335416)
94. Tagami T, Kopp P, Johnson W, Arseven OK and Jameson JL: The thyroid hormone receptor variant apha2 is a weak antagonist because it is deficient in interactions with nuclear receptor corepressors. Endocrinology 139: 2535-2544, 1998. (Pubitemid 28513783)
95. Miyajima N, Horiuchi R, Shibuya Y, Fukushige S, Matsubara K, Toyoshima K and Yamamoto T: Two erbA homologs encoding proteins with different T3 binding capacities are transcribed from opposite DNA strands of the same genetic locus. Cell 57: 31-39, 1989. (Pubitemid 19098866)
96. Spanjaard RA, Nguyen VP and Chin WW: Rat Rev-erbA alpha, an orphan receptor related to TH receptor, binds to specific TH response elements. Mol Endocrinol 8: 286-295, 1994.
97. Segal J: In vivo effect of 3,5,3′-triiodothyronine on calcium uptake in several tissues in the rat: evidence for a physiological role of calcium as a first messenger for the prompt action of thyroid hormone at the level of the plasma membrane. Endocrinology 127: 17-24, 1990.
98. Kavok NS, Krasilnikova OA and Babenko NA: Thyroxine signal transduction in liver cells involves phospholipase C and phospholipase D activation. Genomic independent action of thyroid hormone. BMC Cell Biol 2: 5-12, 2001.
99. D'Arezzo S, Incerpi S, Davis FB, Filippo A, Marino M, Farias RN and Davis PJ: Rapid nongenomic effects of 3,5,3′-triiodo-L-thyronine on the intracellular pH of L-6 myoblasts are mediated by intracellular calcium mobilization and kinase pathways. Endocrinology 145: 5694-5703, 2004. (Pubitemid 39564612)
100. Bergh JJ, Lin HY, Lansing L, Mohamed NS, Davis FB, Moura S and Davis JP: Integrin αVα3 contains a cell surface receptor site for thyroid hormone that is linked to activation of MAPK and induction of angiogenesis. Endocrinology 146: 2864-2871, 2005.
101. Davis PJ, Davis FB and Cody V: Membrane receptors mediating thyroid hormone action. Trends Endocrinol Metab 16: 429-435, 2005. (Pubitemid 41506950)
102. Incerpi S, Scapin S, D'Arezzo S, Spagnuolo S and Leoni S: Short term effects of thyroid hormone in prenatal development and cell differentiation. Steroids 70: 434-443, 2005. (Pubitemid 40616042)
103. Menegaz D, Zamoner A, Royer C, Leite LD, Bartolotto ZA and Silva FR: Rapid responses to thyroxine in the testis: active protein synthesis-independent pathway. Mol Cell Endocrinol 246: 128-134, 2006. (Pubitemid 43238406)
104. Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ and Leonard JL: Dynamic nongenomic actions of thyroid hormone in the developing rat brain. Endocrinology 147: 2567-2574, 2006.
105. Moeller LC, Cao X, Dumitrescu AM, Seo H and Refetoff S: Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor β through the phosphatidylinositol 3-kinase pathway. Nucl Recept Signal 4: 1-4, 2006.
106. 2+ uptake in cerebral cortex from young rats. Neurosci Res 57: 98-103, 2007.
107. Goldfine ID, Simons CG, Smith GH and Ingbar SH: Cycloleucine transport in isolated rat thymocytes: in vitro effects of triiodothyronine and thyroxine. Endocrinology 96: 1030-1038, 1975.
108. Pliam NB and Goldfine ID: High affinity thyroid hormone binding sites on purified rat liver plasma membranes. Biochem Biophys Res Commun 79: 166-172, 1977. (Pubitemid 8221370)
109. Segal J and Gordin A: The effects of actinomycin D, puromycin, cycloheximide and hydroxyurea on 3,5,3′-triiodo-L-thyronine stimulated 2-deoxy-D-glucose uptake in chick embryo heart cells in vitro. Endocrinology 101: 150-156, 1977. (Pubitemid 8141317)
110. Segal J and Ingbar SH: Stimulation by triiodothyronine of the in vitro uptake of sugars by rat thymocytes. J Clin Invest 63: 507-512, 1979.
111. Botta JA, Mendoza D, Morero RD and Farias RN: High affinity L-triiodothyronine binding sites on washed rat erythrocyte membranes. J Biol Chem 258: 6690-6692, 1983.
112. 3H]-uridine transport by thyroid hormone in GH1 cells. J Biol Chem 261: 9000-9004, 1986.
113. Incerpi S, De Vito P, Luly P, Spagnuolo S and Leoni S: Short-term effects of thyroid hormones and 3,5-diiodothyronine on membrane transport systems in chick embryo hepatocytes. Endocrinology 143: 1660-1668, 2002. (Pubitemid 34415880)
114. Storey NM, Gentile S, Ullah H, Russo A, Muessel M, Exleben C and Armstrong DL: Rapid signalling at the plasma membrane by a nuclear receptor for thyroid hormone. Proc Natl Acad Sci USA 103: 5197-5201, 2006.
115. Tang HY, Lin HY, Zhang S, Davis FB and Davis PJ: Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. Endocrinology 145: 3265-3272, 2004. (Pubitemid 38829999)
116. Shih A, Lin HY, Davis FB and Davis PJ: Thyroid hormone promotes serine phosphorylation of p53 by mitogen-activated protein kinase. Biochemistry 40: 2870-2878, 2001. (Pubitemid 32198289)
117. Lin H-Y, Tang H-Y, Shih A, Keating T, Cao G, Davis PJ and Davis FB: Thyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic. Steroids 72: 180-187, 2007. (Pubitemid 46273502)
118. Suzuki S, Mori J-I and Hashizume K: μ-crystallin, a NADPH-dependent T3-binding protein in cytosol. Trends Endocrinol Metab 18: 286-289, 2007. (Pubitemid 47332215)
119. Cannino G, Di Liegro CM and Rinaldi AM: Nuclear-mitochondrial interaction. Mitochondrion 7: 359-366, 2007.
120. Casas F, Rochard P, Rodier A, Cassar-Malek I, Marchal-Victorion S, Wiesner RJ, Cabello G and Wrutniak C: A variant form of the nuclear triiodothyronine receptor c-ErbAalpha1 plays a direct role in regulation of mitochondrial RNA synthesis. Mol Cell Biol 19: 7913-7924, 1999. (Pubitemid 30413986)
121. Casas F, Daury L, Grandemange S, Busson M, Seyer P, Hatier R, Carazo A, Cabello G and Wrutniak-Cabello C: Endocrine regulation of mitochondrial activity: involvement of a truncated RXRalpha and c-ErbAalpha1 proteins. Fed Am Soc Exp Biol J 17: 426-436, 2003. (Pubitemid 36292958)
122. Goldenthal MJ, Ananthakrishnan R and Marin-Garcia J: Nuclear- mitochondrial cross-talk in cardiomyocyte T3 signaling: a time-course analysis. J Mol Cell Cardiol 39: 319-326, 2005. (Pubitemid 40995021)
123. Morrish F, Buroker NE, Ge M, Ning X-H, Lopez-Guisa J, Hockenbery D and Portman MA: Thyroid hormone receptor isoforms localize to cardiac mitochondrial matrix with potential for binding to receptor elements on mtDNA. Mitochondrion 6: 143-148, 2006. (Pubitemid 43872024)
124. Psarra AM, Solakidi S and Sekeris CE: The mitochondrion as a primary site of action of steroid and thyroid hormones: presence and action of steroid and thyroid hormone receptors in mitochondria of animal cells. Mol Cell Endocrinol 246: 21-33, 2006. (Pubitemid 43238393)
125. Santisteban P and Bernal J: Thyroid development and effect on the nervous system. Rev Endocr Metab Disord 6: 217-228, 2005. (Pubitemid 41285599)
126. Taylor PM and Ritchie JWA: Tissue uptake of thyroid hormone by amino acid transporters. Best Pract Res Clin Endocrinol Metab 21: 237-251, 2007.
127. Hagenbuch B: Cellular entry of thyroid hormones by organic anion transporting polypeptides. Best Pract Res Clin Endocrinol Metab 21: 209-221, 2007.
128. Gao B, Hagenbuch B, Kullak-Ublick GA, Benke D, Aguzzi A and Meier PJ: Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J Pharmacol Exp Ther 294: 73-79, 2000. (Pubitemid 30434672)
129. Lee W, Glaeser H, Smith LH, Roberts RL, Moeckel GW, Gervasini G, Leake BF and Kim RB: Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. J Biol Chem 280: 9610-9617, 2005. (Pubitemid 40409657)
130. Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H and Sugiyama Y: Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. J Biol Chem 278: 43489-43495, 2003. (Pubitemid 37345972)
131. Tohyama K, Kusuhara H and Sugiyama Y: Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology 145: 4384-4391, 2004.
132. Robinson D, Prahlad KV and Hampel AE: Amino acid uptake by Xenopus laevis embryos: effect of triiodo-L-thyronine. Comp Biochem Physiol 43: 749-754, 1972.
133. Blondeau JP, Beslin A, Chantoux F and Francon J: Triiodothyronine is a high-affinity inhibitor of amino acid transport system L1 in cultured astrocytes. J Neurochem 60: 1407-1413, 1993. (Pubitemid 23088316)
134. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP and Visser TJ: Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278: 40126-40135, 2003. (Pubitemid 37248580)
135. Dumitrescu AM, Liao XH, Best TB, Brockmann K and Refetoff S: A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 74: 168-175, 2004. (Pubitemid 38085248)
136. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP and Visser TJ: Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364: 1435-1437, 2004. (Pubitemid 39370719)
137. Schwartz CE and Stevenson RE: The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome. Best Pract Res Clin Endocrinol Metab 21: 307-321, 2007. (Pubitemid 46888197)
138. Schwartz CE, May MM, Carpenter NJ Rogers RC, Martin J, Bialer MG, Ward J, Sanabria J, Marsa S, Lewis JA, Echeverri R, Lubs HA, Voeller K, Simensen RJ and Stevenson RE: Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene. Am J Hum Genet 77: 41-53, 2005. (Pubitemid 40848035)
139. Heuer H: The importance of thyroid hormone transporters for brain development and function. Best Pract Res Clin Endocrinol Metab 21: 265-276, 2007.
140. Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ and Bauer K: The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146: 1701-1706, 2005. (Pubitemid 40396877)
141. Suzuki T and Abe T: Thyroid hormone transporters in the brain. Cerebellum 13: 1-9, 2007.
142. Bates JM, St. Germain DL and Galton VA: Expression profiles of the three iodothyronine deiodinases D1, D2 and D3, in the developing rat. Endocrinology 140: 844-851, 1999.
143. Guadaño-Ferraz A, Obregon MJ, St. Germain DL and Bernal J: The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl Acad Sci USA 94: 10391-10396, 1997. (Pubitemid 27407052)
144. Refetoff S, De Wind LT and De Groot LJ: Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormally high PBI: possible target organ refractoriness to thyroid hormones. J Clin Endocrinol Metab 27: 279-294, 1967.
145. Yen PM: Molecular basis of resistance to thyroid hormone. Trends Endocrinol Metab 14: 327-333, 2003. (Pubitemid 37093130)
146. Cheng S-Y: Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance. Trends Endocrinol Metab 16: 176-182, 2005. (Pubitemid 40603097)
147. Refetoff S and Dumitrescu AM: Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cells transporters and deiodination. Best Pract Res Clin Endocrinol Metab 21: 277-305, 2007. (Pubitemid 46888195)
148. Tjorve E, Tjorve KMC, Olsen JO, Senum R and Oftebro H: On commonness and rarity of thyroid hormone resistance: a discussion based on mechanisms of reduced sensitivity in peripheral tissues. Med Hypotheses 69: 913-921, 2007. (Pubitemid 47248107)
149. Usala SJ, Bale AE, Gesundheit N, Weinberger C, Lash RW, Wondisford FE, McBride OW and Weintraub BD: Tight linkage between the syndrome of generalized thyroid hormone resistance and the human c-erb β gene. Mol Endocrinol 2: 1217-1220, 1988. (Pubitemid 19005932)
150. Sakurai A, Takeda K, Ain K, Ceccarelli P, Nakai A, Seino S, Bell GI, Refetoff S and De Groot LJ: Generalized resistance to thyroid hormones associated with a mutation in the ligand-binding domain of the human thyroid hormone receptor b. Proc Natl Acad Sci USA 86: 8977-8981, 1989. (Pubitemid 20010349)
151. Usala SJ, Tennyson GE, Bale AE, Lask RW, Gesudheit N, Wondisford FE, Accili D, Hauser P and Weintraub BD: A base mutation of the cerbAb thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds. J Clin Invest 85: 93-100, 1990. (Pubitemid 20030295)
152. Behr M and Loos U: A point mutation (Ala229 to Thr) in the hinge domain of the c-erbA beta thyroid hormone receptor gene in a family with generalized thyroid hormone resistance. Mol Endocrinol 6: 1119-1126, 1992.
153. Beck-Peccoz P and Chatterjee VK: The variable clinical phenotype in thyroid hormone resistance syndrome. Thyroid 4: 225-232, 1994. (Pubitemid 24202361)
154. Onigata K, Yagi H, Sakurai A, Nagashima T, Nomura Y, Nagashima K,
155. Collingwood TN, Wagner R, Matthews CH, Clifton-Bligh RJ, Gurnell M, Rajanayagam O, Agostini M, Fletterick RJ, Beck-Peccoz P, Reinhardt W, Binder G, Ranke MB, Hermus A, Hesch RD, Lazarus J, Newrick P, Parfitt V, Raggatt P, De Zegher F and Chatterjee VK: A role for helix 3 of the TRbeta ligand-binding domain in coactivator recruitment identified by characterization of a third cluster of mutations in resistance to thyroid hormone. EMBO J 17: 4760-4770, 1998. (Pubitemid 28377176)
156. Kaneshige M, Kaneshige K, Zhu X, Dace A, Garrett L, Carter TA, Kazlauskaite R, Pankratz DG, Wynshaw-Boris A, Refetoff S, Weintraub B, Willingham MC, Barlow C and Cheng S: Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone. Proc Natl Acad Sci USA 97: 13209-13214, 2000.
157. Furuya F, Ying H, Zhao L and Cheng S-Y: Novel functions of thyroid hormone receptor mutants: beyond nucleus-initiated transcription. Steroids 72: 171-179, 2007. (Pubitemid 46273496)
158. Yen PM, Ando S, Feng X, Liu Y, Maruvada P and Xia X: Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol 246: 121-127, 2006. (Pubitemid 43238405)
159. Fardella CE, Artigas RA, Gloger S, Jiménes M, Carvajal CA, Krall PM, Quiroz D, Campino C and Mosso LM: Refractory depression in a patient with peripheral resistance to thyroid hormone (RTH) and the effect of triiodothyronine treatment. Endocrine 31: 272-278, 2007. (Pubitemid 47574980)
160. Legrand J: Thyroid hormone effects on growth and development. In: Thyroid Hormone Metabolism. Henneman G (ed). M Dekker Inc, New York, pp503-534, 1986.
161. Pharoah PO, Buttfield IH and Hetzel BS: Neurological damage to fetus resulting from severe iodine deficiency during pregnancy. Lancet 1: 308-310, 1971.
162. DeLong GR, Stanbury JB and Fierro-Benitez A: Neurological signs in congenital iodine deficiency disorders. Dev Med Child Neurol 27: 317-324, 1985.
163. Stein SA, Adams PM, Shanklin DR, Mihailoff GA and Palnitkar MB: Thyroid hormone control of brain and motor development: molecular, neuroanatomical, and behavioural studies. Adv Exp Med Biol 299: 47-105, 1991.
164. Heyerdahl S: Intellectual development in children with congenital hypothyroidism in relation to T4 replacement. J Pedriatr 118: 850-855, 1991.
165. Haddow JE, Palomaski GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O'Heir CE, Mitchell ML, Hermos RL, Waisbren SE, Faix JD and Klein RZ: Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 341: 549-555, 1999. (Pubitemid 29384162)
166. Pop VJ, Kuijpens JL and van Baar AL: Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psycomotor development in infancy. Clin Endocrinol 50: 149-155, 1999.
167. Bernal J and Pekonen F: Ontogenesis of the nuclear 3,5,3′- triiodothyronine receptor in the human fetal brain. Endocrinology 114: 677-684, 1984. (Pubitemid 14183276)
168. Iskaros J, Pickard M, Evans I, Sinha A, Ardiman P and Ekins R: Thyroid hormone receptor gene expression in first trimester human fetal brain. J Clin Endocrinol Metab 85: 2620-2623, 2000. (Pubitemid 32269224)
169. Perez-Castillo A, Bernal J, Ferreiro B and Pans T: The early ontogenesis of thyroid hormone receptor in the rat fetus. Endocrinology 117: 2457-2461, 1985. (Pubitemid 16194076)
170. Valcana T: The role of triiodothyronine (T3) receptors in brain development. In: Neural Growth and Differentiation. Meisani E and Brazier MAB (eds). Raven Press, New York, pp39-59, 1979.
171. Forrest D, Sjöberg M and Vennström B: Contrasting developmental and tissue-specific expression of α and β thyroid hormone receptor genes. EMBO J 9: 1519-1528, 1990. (Pubitemid 20137008)
172. Strait KA, Schwartz HL, Perez-Castillo A and Oppenheimer JM: Relationship of c-erbA content to tissue triiodothyronine nuclear binding capacity and function in developing and adult rats. J Biol Chem 265: 10514-10521, 1990. (Pubitemid 20212784)
173. Forrest D, Hallböök F, Persson H and Vennström B: Distinct functions for thyroid hormone receptors α and β in brain development indicated by differential expression of receptor genes. EMBO J 10: 269-275, 1991. (Pubitemid 21905476)
174. Strait KA, Schwartz HL, Seybold VS, Ling NC and Oppenheimer JH: Immunofluorescence localization of thyroid hormone receptor beta 1 and variant alpha 2 in selected tissues: cerebellar Purkinje cells as a model for beta 1 receptor-mediated developmental effects of thyroid hormone in brain. Proc Natl Acad Sci USA 88: 3887-3891, 1991.
175. Mellstrom B, Naranjo JR, Santos A, Gonzales AM and Bernal J: Independent expression of the alpha and beta c-erbA genes in developing rat brain. Mol Endocrinol 5: 1339-1350, 1991.
176. Bradley DJ, Towle HC and Young WS III: Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta-2-subtype, in the developing mammalian nervous system. J Neurosci 12: 2288-2302, 1992.
177. Auso E, Lavado-Autric R, Cuevas E, Del Rey FE, Morreale de Escobar G and Berbel P: A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 145: 4037-4047, 2004. (Pubitemid 39120549)
178. Kilby MD, Gittoes N, McCabe C, Verhaeg J and Franklyn JA: Expression of thyroid receptor isoforms in the human fetal central nervous system and the effects of intrauterine growth restriction. Clin Endocrinol 53: 469-477, 2000. (Pubitemid 30802465)
179. Anderson GW, Hagen SG, Larson RJ, Strait KA, Schwartz HL, Mariash CN and Oppenheimer JH: Purkinje cell protein-2 cis-elements mediate repression of T3-dependent transcriptional activation. Mol Cell Endocrinol 131: 79-87, 1997.
180. Giordano T, Pan JB, Casuto D, Watanabe S and Arneric SP: Thyroid hormone regulation of NGF, NT-3 and BDNF RNA in the adult rat brain. Brain Res Mol Brain Res 16: 239-245, 1992.
181. Koibuchi N, Fukuda H and Chin WW: Promoter-specific regulation of the brain derived neurotrophic factor gene by thyroid hormone in the developing rat cerebellum. Endocrinology 140: 3955-3961, 1999. (Pubitemid 30647089)
182. Koibuchi N, Yamaoka S and Chin WW: Effect of altered thyroid status on neurotrophin gene expression during post-natal development of the mouse cerebellum. Thyroid 11: 205-210, 2001. (Pubitemid 32298416)
183. Qiu CH, Shimokawa N, Iwasaki T, Parhar IS and Koibuchi N: Alteration of cerebellar neurotrophin messenger ribonucleic acids and the lack of thyroid hormone receptor augmentation by staggered-type retinoic acid receptor-related orphan receptor-alpha mutation. Endocrinology 148: 1745-1753, 2007. (Pubitemid 46457137)
184. Aniello F, Couchie D, Gripois D and Nunez J: Regulation of five tubulin isotypes by thyroid hormone during brain development. J Neurochem 57: 1781-1786, 1991. (Pubitemid 21922819)
185. Nunez J, Couchie D, Aniello F and Bridoux AM: Regulation by thyroid hormone of microtubule assembly and neuronal differentiation. Neurochem Res 16: 975-982, 1991.
186. Poddar R, Paul S, Chaudhury S and Sarkar PK: Regulation of actin and tubulin gene expression by thyroid hormone during rat brain development. Brain Res Mol Brain Res 35: 111-118, 1996. (Pubitemid 26036738)
187. Benjamin S, Cambray-Deakin MA and Burgoyne RD: Effect of hypothyroidism on the expression of three microtubule-associated proteins (1A, 1B and 2) in developing rat cerebellum. Neuroscience 27: 931-939, 1988. (Pubitemid 19025400)
188. Lorenzo PI, Ménard C, Miller FD and Bernal J: Thyroid hormone-dependent regulation of Tα1 α-tubulin during brain development. Mol Cell Neurosci 19: 333-343, 2002. (Pubitemid 34293457)
189. Aniello F, Couchie D, Bridoux AM, Gripois D and Nunez J: Splicing of juvenile and adult tau mRNA variants is regulated by thyroid hormones. Proc Natl Acad Sci USA 88: 4035-4039, 1991. (Pubitemid 21916759)
190. Cuadrado A, García-Fernández LF, Imai T, Okano H and Muñoz A: Regulation of tau RNA maturation by thyroid hormone is mediated by the neural RNA-binding protein musashi-1. Mol Cell Neurosci 20: 198-210, 2002. (Pubitemid 34762131)
191. Cuadrado A, Navarro-Yubero C, Furneaux H and Muñoz A: Neuronal HuD gene encoding a mRNA stability regulator is transcriptionally repressed by thyroid hormone. J Neurochem 86: 763-773, 2003. (Pubitemid 36897455)
192. Morte B, Iñiguez MA, Lorenzo PI and Bernal J: Thyroid hormone-regulated expression of RC3/neurogranin in the immortalized hypothalamic cell line GT1-7. J Neurochem 69: 902-909, 1997. (Pubitemid 27364809)
193. Vargiu P, Morte B, Manzano J, Perez J, De Abajo R, Gregor Sutcliffe J and Bernal J: Thyroid hormone regulation of rhes, a novel Ras homolog gene expressed in the striatum. Brain Res Mol Brain Res 94: 1-8, 2001. (Pubitemid 32964740)
194. Iglesias T, Caubín J, Stunnenberg HG, Zaballos A, Bernal J and Muñoz A: Thyroid hormone-dependent transcriptional repression of neural cell adhesion molecule during brain maturation. EMBO J 15: 4307-4316, 1996. (Pubitemid 26278713)
195. Lebel JM, L'Hérault S, Dussault JH and Puymirat J: Thyroid hormone up-regulates thyroid hormone receptor beta gene expression in rat cerebral hemisphere astrocyte cultures. Glia 9: 105-112, 1993.
196. Kobayashi K, Tsuji R, Yoshioka T, Kushida M, Yabushita S, Sasaki M, Mino T and Seki T: Effects of hypothyroidism induced by perinatal exposure to PTU on rat behavior and synaptic gene expression. Toxicology 212: 135-147, 2005. (Pubitemid 40981970)
197. Muñoz A, Rodriguez-Peña A, Perez-Castillo A, Ferreiro B, Sutcliffe JG and Bernal J: Effects of neonatal hypothyroidism on rat brain gene expression. Mol Endocrinol 5: 273-280, 1991. (Pubitemid 21923691)
198. Santalucía T, Palacín M and Zorzano A: T3 strongly regulates GLUT1 and GLUT3 mRNA in cerebral cortex of hypothyroid rat neonates. Mol Cell Endocrinol 251: 9-16, 2006. (Pubitemid 43744432)
199. Zhang H-M, Su Q and Luo M: Thyroid hormone regulates the expression of SNAP-25 during rat brain development. Mol Cell Biochem 307: 169-175, 2008. (Pubitemid 350238659)
200. Iannacone EA, Yan AW, Gauger KJ, Dowling ALS and Zoeller RT: Thyroid hormone exerts site-specific effects on SRC-1 and NCoR expression selectively in the neonatal rat brain. Mol Cell Endocrinol 186: 49-59, 2002.
201. Martel J, Cayrou C and Puymirat J: Identification of new thyroid hormone-regulated genes in rat brain neuronal cultures. Neuroreport 13: 1849-1851, 2002.
202. Takahashi M, Negishi T and Tashiro T: Identification of genes mediating thyroid hormone action in the developing mouse cerebellum. J Neurochem: Nov. 14, 2007 (Epub ahead of print).
203. Bass NH and Young E: Effects of hypothyroidism on the differentiation of neurons and glia in developing rat cerebrum. J Neurol Sci 18: 155-173, 1973.
204. Walters SN and Morell P: Effects of altered thyroid states on myelinogenesis. J Neurochem 36: 1792 - 1801, 1981.
205. Clos J, Legrand J, Limozin N, Dalmasso C and Laurent G: Effects of abnormal thyroid state and undernutrition on carbonic anhydrase and oligodendroglia development in the rat cerebellum. Dev Neurosci 5: 243-251, 1982. (Pubitemid 12093839)
206. Ibarrola N, Mayer-Proschel M, Rodriguez-Peña A and Noble M: Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Dev Biol 180: 1-21, 1996. (Pubitemid 26426154)
207. Matthieu J-M, Reier PJ and Sawchak JA: Proteins of rat brain myelin in neonatal hypothyroidism. Brain Res 84: 443-451, 1975.
208. Valcana T, Einstein ER, Csejtey J, Dalal KB and Timiras PS: Influence of thyroid hormones on myelin proteins in the developing rat brain. J Neurol Sci 25: 19-27, 1975.
209. Sarliève LL, Rodriguez-Peña A and Langley K: Expression of thyroid hormone receptor isoforms in the oligodendrocyte lineage. Neurochem Res 29: 903-922, 2004. (Pubitemid 39011340)
210. Koibuchi N, Jingu H, Iwasaki T and Chin WW: Current perspectives on the role of thyroid hormone in growth and development of cerebellum. Cerebellum 2: 279-289, 2003. (Pubitemid 38280285)
211. Raff MC, Lillien LE, Richardson WD, Burne JF and Noble MD: Platelet-derived growth factor fron astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333: 562-565, 1998.
212. Calver AR, Hall AC, Yu WP, Walsh FS, Heath JK, Betsholtz C and Richardson WD: Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20: 869-882, 1998. (Pubitemid 28247393)
213. Gao F-B, Apperly J and Raff M: Cell-intrinsic timers and thyroid hormone regulate the probability of cell cycle withdrawal and differentiation of oligodendrocyte precursor cells. Dev Biol 197: 54-66, 1998. (Pubitemid 28224227)
214. Jones SA, Jolson DM, Cuta KK, Mariash CN and Anderson GW: Triiodothyronine is a survival factors for developing oligodendrocytes. Mol Cell Endocrinol 199: 49-60, 2003.
215. Rodriguez-Peña A: Oligodendrocyte development and thyroid hormone. J Neurobiol 40: 497-512, 1999.
216. Manzano J, Bernal J and Morte B: Influence of thyroid hormones on maturation of rat cerebellar astrocytes. Int J Dev Neurosci 25: 171-179, 2007. (Pubitemid 46636172)
217. Zamoner A, Funchal C, Jacques-Silva MC, Gottfried C, Silva FR and Pessoa-Pureur R: Thyroid hormones reorganize the cytoskeleton of glial cells through gfap phosphorylation and rhoa-dependent mechanisms. Cell Mol Neurobiol 27: 845-865, 2007.
218. Farwell AP, Dubord-Tomasetti SA, Pietrzykowski AZ, Stachelek SJ and Leonard JL: Regulation of cerebellar neuronal migration and neurite outgrowth by thyroxine and 3,3′,5′-triiodothyronine. Brain Res Dev Brain Res 154: 121-135, 2005.
219. Silva JE and Leonard JL: Regulation of rat cerebrocortical and adenohypophyseal type II 5′-deiodinase by thyroxine, triio - dothyronine, and reverse triiodothyronine. Endocrinology 116: 1627-1635, 1985.
220. Leonard JL, Siegrist-Kaiser CA and Zuckerman CJ: Regulation of type II iodothyronine 5′-deiodinase by thyroid hormone. Inhibition of actin polymerization blocks enzyme inactivation in cAMP-stimulated glial cells. J Biol Chem 265: 940-946, 1990. (Pubitemid 20048881)
221. Savettieri G, Licata L, Catania C, Raneri R, Di Liegro I and Cestelli A: Synergistic effects of laminin and thyroid hormones on neuron polarity in culture. Neuroreport 10: 1269-1272, 1999. (Pubitemid 29403707)
222. Cestelli A, Di Liegro I, Castiglia D, Gristina R, Ferraro D, Salemi G and Savettieri G: Triiodothyronine-induced shortening of chromatin repeat length in neurons cultured in a chemically defined medium. J Neurochem 48: 1053-1059, 1987. (Pubitemid 18001326)
223. Cestelli A, Gristina R, Castiglia D, Di Liegro C, Savettieri G, Salemi G and Di Liegro I: The dynamic properties of neuronal chromatin are modulated by triiodothyronine. Neurochem Res 17: 1049-1055, 1992.
224. Scaturro M, Cestelli A, Castiglia D, Nastasi T and Di Liegro I: Posttranscriptional regulation of H1 zero and H3.3B histone genes in differentiating rat cortical neurons. Neurochem Res 20: 969-976, 1995.
225. Derrigo M, Cestelli A, Savettieri G and Di Liegro I: RNA-protein interactions in the control of stability and localization of messenger RNA. J Mol Med 5: 111-123, 2000.
226. Castiglia D, Scaturro M, Nastasi T, Cestelli A and Di Liegro I: PIPPin, a putative RNA-binding protein specifically expressed in the rat brain. Biochem Biophys Res Commun 218: 390-394, 1996. (Pubitemid 26034544)
227. Nastasi T, Scaturro M, Bellafiore M, Raimondi L, Beccari S, Castelli A and Di Liegro I: PIPPin is a brain-specific protein that contains a cold-shock domain and binds specifically to H1° and H3.3 mRNAs. J Biol Chem 274: 24087-24093, 1999. (Pubitemid 129528453)
228. Nastasi T, Muzi P, Beccari S, Dolo V, Bologna M, Cestelli A and Di Liegro I: Specific neurons of brain cortex and cerebellum are PIPPin-positive. Neuroreport 11: 2233-2236, 2000. (Pubitemid 30485568)
229. Cestelli A, Savettieri G, Ferraro D and Vitale F: Formulation of a novel synthetic medium for selectively culturing rat CNS neurons. Dev Brain Res 22: 219-227, 1985. (Pubitemid 16228696)
230. Bono E, Compagno V, Proia P, Raimondi L, Schiera G, Favaloro V, Campo V, Donatelli M and Di Liegro I: Thyroid hormones induce sumoylation of the cold shock domain-containing protein PIPPin in developing rat brain and in cultured neurons. Endocrinology 148: 252-257, 2007. (Pubitemid 46021457)
231. Croteau W, Davey JC, Galton VA and St. Germain DL: Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 98: 405-417, 1996. (Pubitemid 26255740)
232. Guadano-Ferraz A, Escamez MJ, Rausell E and Bernal J: Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems. J Neurosci 19: 3430-3439, 1999. (Pubitemid 29203123)
233. Tu HM, Kim SW, Salvatore D, Bartha T, Legradi G, Larsen PR and Lechan RM: Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology 138: 3359-3368, 1997. (Pubitemid 27345689)
234. Galton VA, Wood ET, St. Germain EA, Withrow CA, Aldrich G, St. Germain GM, Clark AS and St. Germain DL: Thyroid hormone homeostasis and action in the type 2 deiodinase-deficient rodent brain during development. Endocrinology 148: 3080-3088, 2007. (Pubitemid 46997018)
235. Samuels MH, Schuff KG, Carlson NE, Carello P and Janowsky JS: Health status, mood, and cognition in experimentally induced subclinical hypothyroidism. J Clin Endocrinol Metab 92: 2545-2551, 2007. (Pubitemid 47037356)
236. Miller KJ, Parsons TD, Whybrow PC, Van Herle K, Rasgon N, Van Herle A, Martinez D, Silverman DH and Bauer M: Verbal memory retrieval deficits associated with untreated hypothyroidism. J Neuropsychiatry Clin Neurosci 19: 132-138, 2007. (Pubitemid 46649635)
237. Bauer MS and Whybrow PC: Thyroid hormones and the central nervous system in affective illness: interactions that may have clinical significance. Integr Psychiatr 6: 75-100, 1988.
238. Arem R and Cusi K: Thyroid function testing in psychiatric illness - usefulness and limitations. Trends Endocrinol Metab 8: 282-287, 1997. (Pubitemid 27424206)
239. Rivas M and Naranjo JR: Thyroid hormones, learning and memory. Genes Brain Behav 6 (Suppl 1): 40-44, 2007.
240. Desouza LA, Ladiwala U, Daniel SM, Agashe S, Vaidya R and Vaidya VA: Thyroid hormone regulates hippocampal neurogenesis in the adult rat brain. Mol Cell Neurosci 29: 414-426, 2005. (Pubitemid 40799214)
241. Clower CG: Organic affective syndromes associated with thyroid disfunction. Psychiatr Med 2: 177-181, 1984.
242. White AJ and Barraclough B: Thyroid disease and mental illness: a study of thyroid disease in psychiatric admissions. J Psychosom Res 32: 99-106, 1988.
243. Brunello N: Mood stabilizers: protecting the mood, protecting the brain. J Affect Disord 79: S15-S20, 2004.
244. Hahn C-G, Pawlyk AC, Whybrow PC, Gyulai L and Tejani-Butt SM: Lithium administration affects gene expression of thyroid hormone receptors in rat brain. Life Sci 64: 1793 - 1802, 1999.
245. Constantinou C, Bolaris S, Valcana T and Margarity M: Acute LiCl-treatment affects the cytoplasmic T4 availability and the expression pattern of thyroid hormone receptors in adult rat cerebral hemispheres. Neurosci Res 51: 235-241, 2005. (Pubitemid 40248546)
246. Constantinou C, Bolaris S, Valcana T and Margarity M: Diazepam affects the nuclear thyroid hormone receptor density and their expression levels in adult rat brain. Neurosci Res 52: 269-275, 2005. (Pubitemid 40775766)
247. Joffe RT, Sokolov TH and Singer W: Thyroid hormone treatment of depression. Thyroid 5: 235-239, 1995.
248. Prange AJ: Novel uses of thyroid hormones in patient with affective disorders. Thyroid 6: 537-543, 1996.
249. Kulikov AV and Zubkov EA: Chronic thyroxine treatment activates the 5-HT2A serotonin receptor in the mouse brain. Neurosci Lett 416: 307-309, 2007.
250. Franklin RJM: Why does remyelination fail in multiple sclerosis? Nat Rev 3: 705-714, 2002.
251. Calzà L, Fernandez M, Giuliani A, D'Intino G, Pirondi S, Sivilia S, Paradisi M, DeSordi N and Giardino L: Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease. Brain Res Rev 48: 339-346, 2005. (Pubitemid 40585764)
252. Davis RL, Shrimpton AE, Holohan PD, Bradshaw C, Feiglin D, Collins GH, Sonderegger P, Kinter J, Becker LM, Lacbawan F, Krasnewich D, Muenke M, Lawrence DA, Yerby MS, Shaw CM, Gooptu B, Elliott PR, Finch JT, Carrell RW and Lomas DA: Familial dementia caused by polymerization of mutant neuroserpin. Nature 401: 376-379, 1999. (Pubitemid 29454960)
253. Navarro-Yubero C, Cuadrado A, Sonderegger P and Munoz A: Neuroserpin is post-transcriptionally regulated by thyroid hormone. Mol Brain Res 123: 56-65, 2004. (Pubitemid 38392064)